| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.78M | - | |
| Dir | 164.0K | $12.46M | -8,000 | |
| VP | 100.3K | $7.62M | - | |
| VP | 83.3K | $6.33M | -60,846 | |
| CFO | 82.7K | $6.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2019 | Klein Joseph III60 | Director | Sale+OE | 1,000 | $63.74 | $63,744.70 | -7.3% | |
| Dec 4, 2019 | Hougen Elizabeth L55 | SVP, Finance &CFO | Sale+OE | 4,566 | $65.00 | $296,790.00 | -10.2% | |
| Dec 4, 2019 | Geary Richard S65 | SVP, Development | Sale+OE | 10,000 | $65.00 | $650,000.00 | -31.7% | |
| Dec 2, 2019 | Klein Joseph III60 | Director | Sale+OE | 1,000 | $64.08 | $64,083.00 | -7.3% | |
| Dec 2, 2019 | Geary Richard S65 | SVP, Development | Sale+OE | 5,000 | $65.06 | $325,287.00 | -18.8% | |
| Nov 25, 2019 | Klein Joseph III60 | Director | Sell | 812 | $62.90 | $51,074.80 | -6.0% | |
| Nov 25, 2019 | Hougen Elizabeth L55 | SVP, Finance &CFO | Sale+OE | 4,000 | $62.50 | $250,000.00 | -16.6% | |
| Nov 20, 2019 | Klein Joseph III60 | Director | Sell | 2,000 | $60.00 | $120,000.00 | -12.9% | |
| Nov 20, 2019 | Monia Brett P60 | COO &SVP, Translational Med | Sell | 5,776 | $60.01 | $346,617.76 | -26.0% | |
| Nov 19, 2019 | Hougen Elizabeth L55 | SVP, Finance &CFO | Sale+OE | 4,000 | $58.80 | $235,200.00 | -16.6% |